ResearcherXi'an Jiaotong UniversityNo recent work listed

Cangang Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6443-7023; OpenAlex author ID A5013624246. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 2 papers

Papers 2

BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma. First author DOI 10.1155/2021/7842035 ↗
Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. Co-author DOI 10.3389/fmed.2021.649326 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongyan Zhao · 1 shared paper, 2021 · strength 0.15
- Paper BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma. DOI 10.1155/2021/7842035 ↗
Wenhua Li · 1 shared paper, 2021 · strength 0.15
- Paper BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma. DOI 10.1155/2021/7842035 ↗
Yanan Zhu · 1 shared paper, 2021 · strength 0.15
- Paper BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma. DOI 10.1155/2021/7842035 ↗
Yi Liu · 1 shared paper, 2021 · strength 0.14
- Paper Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. DOI 10.3389/fmed.2021.649326 ↗
Haibo Liu · 1 shared paper, 2021 · strength 0.14
- Paper Three Immune-Related Prognostic mRNAs as Therapeutic Targets for Pancreatic Cancer. DOI 10.3389/fmed.2021.649326 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.